dual gip/glp-1 receptor agonist Tirzepatide, a co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction - Cardiovascular Diabetology GLP-1 vs GIP vs Dual
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2






















